These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10552082)

  • 1. Logistic discriminant parametric mapping: a novel method for the pixel-based differential diagnosis of Parkinson's disease.
    Acton PD; Mozley PD; Kung HF
    Eur J Nucl Med; 1999 Nov; 26(11):1413-23. PubMed ID: 10552082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers.
    Mozley PD; Schneider JS; Acton PD; Plössl K; Stern MB; Siderowf A; Leopold NA; Li PY; Alavi A; Kung HF
    J Nucl Med; 2000 Apr; 41(4):584-9. PubMed ID: 10768556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism.
    Booij J; Speelman JD; Horstink MW; Wolters EC
    Eur J Nucl Med; 2001 Mar; 28(3):266-72. PubMed ID: 11315592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease.
    Swanson RL; Newberg AB; Acton PD; Siderowf A; Wintering N; Alavi A; Mozley PD; Plossl K; Udeshi M; Hurtig H
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):302-7. PubMed ID: 15791439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease.
    Lynch DR; Mozley PD; Sokol S; Maas NM; Balcer LJ; Siderowf AD
    Mov Disord; 2003 Jul; 18(7):804-12. PubMed ID: 12815660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of dopamine transporters with technetium-99m TRODAT-1 and single photon emission computed tomography.
    Bao SY; Wu JC; Luo WF; Fang P; Liu ZL; Tang J
    J Neuroimaging; 2000 Oct; 10(4):200-3. PubMed ID: 11147397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease.
    Hwang WJ; Yao WJ; Wey SP; Ting G
    J Nucl Med; 2004 Feb; 45(2):207-13. PubMed ID: 14960637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The optimal imaging time for [99Tcm]TRODAT-1/SPET in normal subjects and patients with Parkinson's disease.
    Kao PF; Tzen KY; Yen TC; Lu CS; Weng YH; Wey SP; Ting G
    Nucl Med Commun; 2001 Feb; 22(2):151-4. PubMed ID: 11258401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomography.
    Tatsch K; Schwarz J; Mozley PD; Linke R; Pogarell O; Oertel WH; Fieber RS; Hahn K; Kung HF
    Eur J Nucl Med; 1997 Apr; 24(4):415-21. PubMed ID: 9096093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Imaging of dopamine transporter with Tc99m-Trodat-SPECT in movement disorders].
    Kanyó B; Argyelán M; Dibó G; Szakonyi Z; Vécsei L; Fülöp F; Láncz A; Forgács P; Pávics L
    Ideggyogy Sz; 2003 Jul; 56(7-8):231-40. PubMed ID: 12971118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single photon emission computer tomography of dopamine transporters in monkeys and humans with 99mTc-TRODAT-1.
    Hu P; Chen L; Zhang HQ; Li JR; Liang H
    Chin Med J (Engl); 2004 Jul; 117(7):1056-9. PubMed ID: 15265382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99mTc-TRODAT-1 imaging of multiple system atrophy.
    Lu CS; Weng YH; Chen MC; Chen RS; Tzen KY; Wey SP; Ting G; Chang HC; Yen TC
    J Nucl Med; 2004 Jan; 45(1):49-55. PubMed ID: 14734673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simplified reference region model for the kinetic analysis of [99mTc]TRODAT-1 binding to dopamine transporters in nonhuman primates using single-photon emission tomography.
    Acton PD; Kushner SA; Kung MP; Mozley PD; Plössl K; Kung HF
    Eur J Nucl Med; 1999 May; 26(5):518-26. PubMed ID: 10382097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substantia nigra echogenicity and imaging of striatal dopamine transporters in Parkinson's disease: a cross-sectional study.
    Bor-Seng-Shu E; Pedroso JL; Felicio AC; de Andrade DC; Teixeira MJ; Braga-Neto P; Batista IR; Barsottini OG; Borges V; Ferraz HB; Shih MC; Bressan RA; de Andrade LA; Walter U
    Parkinsonism Relat Disord; 2014 May; 20(5):477-81. PubMed ID: 24629800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease.
    Scherfler C; Seppi K; Donnemiller E; Goebel G; Brenneis C; Virgolini I; Wenning GK; Poewe W
    Brain; 2005 Jul; 128(Pt 7):1605-12. PubMed ID: 15817519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT.
    Booij J; Hemelaar TG; Speelman JD; de Bruin K; Janssen AG; van Royen EA
    J Nucl Med; 1999 May; 40(5):753-61. PubMed ID: 10319746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson's disease patients.
    Hsiao IT; Weng YH; Lin WY; Hsieh CJ; Wey SP; Yen TC; Kung MP; Lu CS; Lin KJ
    Nucl Med Biol; 2014 Apr; 41(4):322-9. PubMed ID: 24503330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects.
    Weng YH; Yen TC; Chen MC; Kao PF; Tzen KY; Chen RS; Wey SP; Ting G; Lu CS
    J Nucl Med; 2004 Mar; 45(3):393-401. PubMed ID: 15001678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: a PET study.
    Ma Y; Dhawan V; Mentis M; Chaly T; Spetsieris PG; Eidelberg D
    Synapse; 2002 Aug; 45(2):125-33. PubMed ID: 12112405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging and quantitation of dopamine transporters with iodine-123-IPT in normal and Parkinson's disease subjects.
    Kim HJ; Im JH; Yang SO; Moon DH; Ryu JS; Bong JK; Nam KP; Cheon JH; Lee MC; Lee HK
    J Nucl Med; 1997 Nov; 38(11):1703-11. PubMed ID: 9374337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.